Expression of SLC7A11, GPX4 and ACSL4 in nasopharyngeal carcinoma and their correlation with radiotherapy resistance.
10.13201/j.issn.2096-7993.2025.05.013
- Author:
Donghui YAN
1
;
Yanyan ZHENG
1
;
Ningxiang ZENG
1
;
Hongxun GONG
1
;
Yanqiu HUANG
1
;
Maoxin WANG
1
Author Information
1. Department of Otolaryngology Head and Neck Surgery，900 Hospital of the Joint Logistics Team，Fuzhou，350025，China.
- Publication Type:Journal Article
- Keywords:
ACSL4;
GPX4;
SLC7A11;
ferroptosis;
nasopharyngeal carcinoma;
resistance to radiotherapy
- MeSH:
Humans;
Nasopharyngeal Carcinoma/radiotherapy*;
Nasopharyngeal Neoplasms/pathology*;
Coenzyme A Ligases/metabolism*;
Radiation Tolerance;
Phospholipid Hydroperoxide Glutathione Peroxidase;
Amino Acid Transport System y+/metabolism*;
Prognosis;
Long-Chain-Fatty-Acid-CoA Ligase;
Retrospective Studies;
Ferroptosis;
Male;
Female;
Middle Aged
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2025;39(5):462-469
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the correlation between ferroptosis-related proteins SLC7A11, GPX4, ACSL4 and the radiosensitivity and prognosis of nasopharyngeal carcinoma. And to investigate the potential of these proteins as molecular markers for predicting the radiosensitivity of nasopharyngeal carcinoma. Methods: A retrospective analysis was conducted on 52 cases of nasopharyngeal carcinoma （nasopharyngeal carcinoma group） and 20 cases of chronic nasopharyngiti s（control group）. The relevant clinical data were reviewed, and paraffin-embedded tissue blocks were collected for study. The expressions of SLC7A11, GPX4, and ACSL4 in pathological specimens were detected by immunohistochemical staining. The expression differences of ferroptosis-related proteins between the nasopharyngeal carcinoma group and the control group were analyzed. The nasopharyngeal carcinoma group was further divided based on the protein expression levels into high and low expression subgroups for SLC7A11, GPX4, and ACSL4. Subsequently, a differential analysis of clinical data and survival analysis was conducted for each of these subgroups. Finally, logistic regression analysis was performed to identify the factors influencing radiotherapy resistance in nasopharyngeal carcinoma. Results:①The differential analysis revealed that, compared to the control group, the nasopharyngeal carcinoma group exhibited significantly higher expression of SLC7A11 and GPX4, and lower expression of ACSL4 （P<0.05）. ②Notably, the proportion of patients displaying radioresistance was higher in the SLC7A11 and GPX4 high expression groups compared to their respective low expression groups （P<0.05）. However, the proportion of radioresistance in the ACSL4 high expression group was lower than that in the ACSL4 low expression group （P<0.05）. Survival analysis indicated that the 5-year overall survival rate was lower in the SLC7A11 and GPX4 high expression groups compared to their respective low expression groups（P<0.05）. However, the 5-year overall survival rate of the ACSL4 high expression group was higher than that of the ACSL4 low expression group（P<0.05）. ③logistic regression analysis showed that SLC7A11 and GPX4 was an independent risk factor for radioresistance in patients with nasopharyngeal carcinoma（P<0.05）. Conclusion:Nasopharyngeal carcinoma tissues over-express SLC7A11, GPX4, and under-express ACSL4. Over-expression of SLC7A11 and GPX4 are independent risk factors for radioresistance in patients with nasopharyngeal carcinoma. The inhibition of ferroptosis may be related to the occurrence, progression and radioresistance of nasopharyngeal carcinoma. Detection of the expression of SLC7A11, GPX4, and ACSL4 has guiding significance for the evaluation of radiosensitivity and prognosis of patients with nasopharyngeal carcinoma.
